66 results on '"Wallwiener D"'
Search Results
2. Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients
3. Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression†
4. Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2− early breast cancer: WSG-AGO EC-Doc Trial
5. Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression†
6. TGFβ1 and SGK1-sensitive store-operated Ca2+ entry and Orai1 expression in endometrial Ishikawa cells
7. Electronic Psychooncological Screening of Cancer Patients (ePOS): Diagnostics and Clinical Pathways: ID 043
8. Ten years of successful oncologic quality assurance in certified breast centres in Germany: ID 261
9. Hsa-miR-199a-5p is functionally relevant in progression from ductal carcinoma in situ to invasive breast tumours: ID 187
10. Differentielle Expression von Transkripten und mikroRNAs während der Progression des Mammakarzinoms: ID 185
11. HER1, HER2, HER3 and HER4 - clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer: ID 016
12. Application of integrative medicine by postmenopausal breast cancer patients in the PreFace Phase IV study - a prospective, longitudinal trial: ID 270
13. The prognostic relevance of disseminated tumor cells in primary breast cancer patients - results from a large single-center study: ID 262
14. Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ: ID 327
15. COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy
16. Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients
17. The embryonic protein SOX2 modulates growth and apoptosis sensitivity in a subset of ovarian carcinomas: V758
18. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery
19. Influence of aminobisphosphonates on molecular and cellular functions of human osteoblasts: V436
20. Selected Abstract Expression of the embryonic self-renewal protein NANOG predicts higher tumor aggressiveness in human breast cancer samples: V263
21. Intra- and interoperator reliability of manual and semi-automated measurement of fetal nuchal translucency by sonographers with different levels of experience
22. Effect of deviation from the mid-sagittal plane on the measurement of fetal nuchal translucency
23. Interactions between breast cancer cells and the bone marrow microenvironment: PO578
24. Persistierende disseminierte Tumorzellen beim Mammakarzinom - Stammzellproteine als mögliche Marker für Therapieresistenz?: PO232
25. Identification of self-renewal pathways in breast cancer stem cells: PO230
26. Parvovirus H-1 is cytotoxic for human breast cancer cells: PO533
27. Laparoskopische Techniken in der Gynäkologischen Onkologie - Einführung in die klinische Routine: PO541
28. Complications in Laparoscopic Gynecologic Oncology: PO542
29. Endoskopische Sentinel-Techniken bei gynäkologischen Karzinomen - Aspekte zur Technik und Machbarkeit in der klinischen Routine: PO540
30. Ist ein aggressives chirurgisches Vorgehen mit Darmteilresektion beim fortgeschrittenen Ovarialcarzinom günstig für die Prognose?: PO202
31. Bedeutung einer pelvinen und paraaortalen Lymphonodektomie für Gesamtüberleben und rezidivfreies Überleben beim Ovarialcarzinom.: PO205
32. Does the number of hysteroscopies and the time interval between hysteroscopy and surgery influence the result of peritoneal cytology in patients with endometrial cancer: FV417
33. Zoledronsäure - eine kosteneffektive Therapie in der adjuvanten Situation von Patientinnen mit einem Mammakarzinom. Ergebnisse des Zometa®-Kosten-Nutzwert-Modells für das deutsche Gesundheitssystem auf Grundlage der Ergebnisse der ABCSG-12-Studie: PO605
34. Influence of surgery on circulating tumor cells in primary breast cancer patients: PO070
35. Arimidex: COMPliance and Arthralgias in Clinical Therapy (COMPACT)Assessment of the incidence of arthralgia, therapy costs and compliance within the first year of anastrozole therapy: PO177
36. Pilotstudie zur Evaluation sonographischer Dignitätskriterien axillärer Lymphknoten (axLN) beim Mammakarzinom vor prätherapeutischer Abklärung mittels Feinnadelaspiration (FNA): PO175
37. Detection of disseminated tumor cells in patients with ductal intraepithelial neoplasia of the breast: PO068
38. HER2-Status von persistierenden disseminerten Tumorzellen von Mammakarzinompatientinnen: PO062
39. Pilotstudie zur Feinnadelaspiration (FNA) axillärer Lymphknoten (axLN) beim Mammakarzinom: PO066
40. Allogeneic vaccination with an immunocompetent CD80transfected tumor cell line: advanced breast cancer patients show T-cell responses predicting a better clinical outcome: PO508
41. Einfluss von PGRMC1 auf die Expression und Aktivierung von Signalproteinen: PO043
42. Differentielle Expression von miRNA und deren Kandidatengene beim Übergang von DCIS zum IDC beim Mammakarzinom: PP406
43. Identifizierung und Validierung von Progressionsmarkern beim Mammakarzinom aus Paraffingewebe: FV107
44. Haben neoadjuvante Therapien einen Einfluβ auf disseminierte Tumorzellen im Knochenmark und zirkulierende Tumorzellen im Blut?: PP302
45. eLEcTRA trial: Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first line treatment in patients with hormone-receptor-positive, HER2- positive metastatic breast cancer (MBC): PP301
46. Higher incidence of linked malformations in siblings of Mayer–Rokitansky–Küster–Hauser-syndrome patients
47. Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine
48. Complete extirpation of benign breast lesions with an ultrasound-guided vacuum biopsy system
49. Breast cancer patientsʼ expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients
50. Different effects of estradiol and various antiestrogens on TNF-α-induced changes of biochemical markers for growth and invasion of human breast cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.